Andere Sprachen iCon Group Ltd

Aktien

A409H4

IL0011824849

ICON

Verzögert TEL AVIV STOCK EXCHANGE Andere Börsenplätze 12:18:26 05.05.2024			% 5 Tage	% 1. Jan.
460.6 ^ILa	+0.50%		-1.62%	-1.58%

28.03.	ICon Group Ltd. meldet Ergebnis für das Geschäftsjahr zum 31. Dezember 2023	CI
2023	ICon Group Ltd. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 30. September 2023	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

ICon Group Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	28.03.
Radformation and Icon Group Unite to Transform Cancer Treatment and Workflows	14.02.
Icon Group - Meet Our National Operations Manager for the UK, Claire Smith	12.02.
Bowel Cancer Australia and Icon Cancer Centre announce new partnership to help close the care gap	08.02.
Icon Singapore holds inaugural Regional Oncology Conference	30.01.
Icon Singapore holds inaugural Radiation Oncology Conference	29.01.
Icon - New radiation therapy service to give patients better access, more choice to cancer care	26.01.
Icon Group and Nuffield Health announce next phase in strategic partnership for the delivery of oncology services in the UK	12.01.
Icon Group celebrates a year of growth and pioneering advancements in healthcare	18.12.
ICON secures upgraded credit rating from Moody's Investors Service	08.12.
ICon Group Ltd Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	29.11.
Icon Group Appoints Russell Hill as Chief Operating Officer for Pharmacy	29.11.
Russell Hill appointed to Icon's Chief Operating Officer for Pharmacy	29.11.
Icon takes centre stage at London Global Cancer Week	22.11.
Icon Group - Slade Pharmacy wins contract to provide pharmacy services for UnitingCare Queensland hospitals	19.10.23
Icon Sunsuria set to open its first cancer centre in Island Hospital	18.10.23
Icon launches theranostics, a personalised approach to cancer treatment	10.10.23
Icon Group leads global initiative to support cancer care in war-torn Ukraine	28.09.23
ICon Group Ltd Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	30.08.23
Icon appoints new Group Director of Research	27.07.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen iCon Group Ltd

Aktien

A409H4

IL0011824849

ICON

Andere Sprachen

Filter